These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 12270968

  • 1. Analysis of direct hospital costs before and 18 months after treatment with vagus nerve stimulation therapy in 43 patients.
    Ben-Menachem E, Hellström K, Verstappen D.
    Neurology; 2002 Sep 24; 59(6 Suppl 4):S44-7. PubMed ID: 12270968
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
    Purser MF, Mladsi DM, Beckman A, Barion F, Forsey J.
    Adv Ther; 2018 Oct 24; 35(10):1686-1696. PubMed ID: 30143957
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vagus nerve stimulation therapy in a developing country: a long term follow up study and cost utility analysis.
    Aburahma SK, Alzoubi FQ, Hammouri HM, Masri A.
    Seizure; 2015 Feb 24; 25():167-72. PubMed ID: 25468513
    [Abstract] [Full Text] [Related]

  • 7. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C, Shankar R, Barion F, Pollit V, Murphy J, Sawyer L, Danielson V.
    J Med Econ; 2021 Feb 24; 24(1):1037-1051. PubMed ID: 34348576
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vagus nerve stimulation for treatment of partial seizures: 2. Safety, side effects, and tolerability. First International Vagus Nerve Stimulation Study Group.
    Ramsay RE, Uthman BM, Augustinsson LE, Upton AR, Naritoku D, Willis J, Treig T, Barolat G, Wernicke JF.
    Epilepsia; 1994 Feb 24; 35(3):627-36. PubMed ID: 8026409
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. Vagus Nerve Stimulation Study Group.
    Salinsky MC, Uthman BM, Ristanovic RK, Wernicke JF, Tarver WB.
    Arch Neurol; 1996 Nov 24; 53(11):1176-80. PubMed ID: 8912492
    [Abstract] [Full Text] [Related]

  • 13. Cost-benefit of vagus nerve stimulation for refractory epilepsy.
    Boon P, Vonck K, D'Have M, O'Connor S, Vandekerckhove T, De Reuck J.
    Acta Neurol Belg; 1999 Dec 24; 99(4):275-80. PubMed ID: 10674145
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
    Helmers SL, Duh MS, Guérin A, Sarda SP, Samuelson TM, Bunker MT, Olin BD, Jackson SD, Faught E.
    Eur J Paediatr Neurol; 2012 Sep 24; 16(5):449-58. PubMed ID: 22261080
    [Abstract] [Full Text] [Related]

  • 15. EuroSCORE predicts intensive care unit stay and costs of open heart surgery.
    Nilsson J, Algotsson L, Höglund P, Lührs C, Brandt J.
    Ann Thorac Surg; 2004 Nov 24; 78(5):1528-34. PubMed ID: 15511424
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.